ResMed revenue surges on ventilator push

April 30, 2020
Increased production of ventilators for COVID-19 treatment has boosted revenue significantly at ASX-listed health firm ResMed.

from The West Australian https://ift.tt/3aUfCNQ

Leave a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.